These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24930730)

  • 1. Impacts of COX-1 gene polymorphisms on vascular outcomes in patients with ischemic stroke and treated with aspirin.
    Cao L; Zhang Z; Sun W; Bai W; Sun W; Zhang Y; Wang X; Cai B; Xie X; Duan Z; Cai Q; Liu D; Xiong Y; Ma M; Liu X; Xu G
    Gene; 2014 Aug; 546(2):172-6. PubMed ID: 24930730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between PTGS1 polymorphisms and functional outcomes in Chinese patients with stroke during aspirin therapy: Interaction with smoking.
    Cai H; Cai B; Sun L; Zhang H; Zhou S; Cao L; Guo H; Sun W; Yan B; Davis SM; Zhang Z; Liu X
    J Neurol Sci; 2017 May; 376():211-215. PubMed ID: 28431615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
    Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
    J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population.
    Zhao L; Fang J; Zhou M; Zhou J; Yu L; Chen N; He L
    BMC Neurol; 2019 Nov; 19(1):291. PubMed ID: 31735164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.
    Sun W; Li Y; Li J; Zhang Z; Zhu W; Liu W; Cai Q; Wang X; Cao L; Bai W; Fan X; Ma M; Guo R; Liu X; Xu G
    Platelets; 2015; 26(6):558-62. PubMed ID: 25207801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of C3435T multi drug resistance gene-1 polymorphism with aspirin resistance in ischemic stroke and its subtypes.
    Sharma V; Kaul S; Al-Hazzani A; Prabha TS; Rao PP; Dadheech S; Jyothy A; Munshi A
    J Neurol Sci; 2012 Apr; 315(1-2):72-6. PubMed ID: 22177087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
    Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
    Li Q; Chen BL; Ozdemir V; Ji W; Mao YM; Wang LC; Lei HP; Fan L; Zhang W; Liu J; Zhou HH
    Pharmacogenomics; 2007 Jun; 8(6):577-86. PubMed ID: 17559347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
    J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ALOX5AP1 SG13S114T/A variant with ischemic stroke, stroke subtypes and aspirin resistance.
    Sharma V; Dadheech S; Kaul S; Jyothy A; Munshi A
    J Neurol Sci; 2013 Aug; 331(1-2):108-13. PubMed ID: 23746795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention.
    Chiu FC; Wang TD; Lee JK; Shih FY; Lin JW; Huang CH; Chen WJ; Chen MF
    Eur J Intern Med; 2011 Oct; 22(5):471-7. PubMed ID: 21925055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between methylenetrahydrofolate reductase gene and ischemic stroke].
    Li CM; Zhang C; Lu XL; Feng HY; Su QX; Zeng Y; Zhang HL; Qiu SL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):264-7. PubMed ID: 16700986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin.
    Kim JT; Park MS; Choi KH; Cho KH; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko YC; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim DE; Ryu WS; Shin DI; Yeo MJ; Kim WJ; Lee J; Lee JS; Saver JL; Bae HJ
    Stroke; 2016 Jan; 47(1):128-34. PubMed ID: 26604247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of COX-2 rs20417 with aspirin resistance.
    Sharma V; Kaul S; Al-Hazzani A; Alshatwi AA; Jyothy A; Munshi A
    J Thromb Thrombolysis; 2013 Jan; 35(1):95-9. PubMed ID: 22763923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.